JFA
EBS icon

JNBA Financial Advisors’s Emergent Biosolutions EBS Stock Holding History

JNBA Financial Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-328
Closed -$2.89K – 804
2025
Q3 		$2.89K Hold
328
– – ﹤0.01% 590
2025
Q2 		$2.09K Hold
328
– – ﹤0.01% 592
2025
Q1 		$1.59K Hold
328
– – ﹤0.01% 607
2024
Q4 		$3.14K Hold
328
– – ﹤0.01% 569
2024
Q3 		$2.74K Hold
328
– – ﹤0.01% 586
2024
Q2 		$2.24K Hold
328
– – ﹤0.01% 573
2024
Q1 		$830 Hold
328
– – ﹤0.01% 640
2023
Q4 		$788 Hold
328
– – ﹤0.01% 661
2023
Q3 		$1.12K Buy
+328
New +$1.82K ﹤0.01% 660

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JNBA Financial Advisors's EBS Position: Q4 2025 in Review

JNBA Financial Advisors sold out of Emergent Biosolutions (EBS) in Q4 2025, closing a stake of 328 shares — an estimated $2.89K sold.

JNBA Financial Advisors first reported a position in EBS in Q3 2023 and held it in 9 quarters. The position peaked at $3.14K in Q4 2024. 183 funds tracked by Wall St. Rank hold EBS as of Q4 2025.

  • JNBA Financial Advisors reported no remaining Emergent Biosolutions position as of Q4 2025 after selling out during the quarter.
  • JNBA Financial Advisors sold 328 Emergent Biosolutions shares in Q4 2025, an estimated $2.89K.
  • JNBA Financial Advisors first reported a position in Emergent Biosolutions in Q3 2023 and held it in 9 quarters.
  • JNBA Financial Advisors's Emergent Biosolutions position peaked at $3.14K in Q4 2024.
  • 183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2025.

Based on JNBA Financial Advisors's 13F filing for Q4 2025, filed 26 Jan 2026.